BOREA, Pier Andrea
 Distribuzione geografica
Continente #
NA - Nord America 34.718
EU - Europa 12.310
AS - Asia 8.072
SA - Sud America 32
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 24
AF - Africa 10
Totale 55.192
Nazione #
US - Stati Uniti d'America 34.644
CN - Cina 4.184
UA - Ucraina 2.961
IT - Italia 2.745
DE - Germania 2.553
TR - Turchia 2.186
SG - Singapore 1.329
GB - Regno Unito 1.214
SE - Svezia 1.051
FI - Finlandia 695
RU - Federazione Russa 275
PL - Polonia 259
FR - Francia 199
BE - Belgio 106
HK - Hong Kong 105
ID - Indonesia 82
NL - Olanda 69
CA - Canada 68
CZ - Repubblica Ceca 67
VN - Vietnam 48
IN - India 41
IR - Iran 33
AU - Australia 21
EU - Europa 21
ES - Italia 20
LT - Lituania 20
CL - Cile 13
KR - Corea 13
RO - Romania 13
AT - Austria 12
JP - Giappone 11
BR - Brasile 10
IL - Israele 8
IE - Irlanda 7
AR - Argentina 6
CH - Svizzera 6
PT - Portogallo 6
TW - Taiwan 6
GR - Grecia 5
MY - Malesia 5
NZ - Nuova Zelanda 5
HR - Croazia 4
HU - Ungheria 4
MX - Messico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
BG - Bulgaria 3
DZ - Algeria 3
EG - Egitto 3
IM - Isola di Man 3
MA - Marocco 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
IQ - Iraq 2
JO - Giordania 2
LB - Libano 2
MD - Moldavia 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
KH - Cambogia 1
MC - Monaco 1
ME - Montenegro 1
NI - Nicaragua 1
NP - Nepal 1
PK - Pakistan 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 55.192
Città #
Woodbridge 4.579
Fairfield 3.672
Jacksonville 3.290
Chandler 2.908
Houston 2.826
Ann Arbor 2.404
Ashburn 2.049
Wilmington 1.651
Seattle 1.514
Cambridge 1.157
Izmir 1.118
Nanjing 1.015
Singapore 943
Beijing 714
Princeton 711
Boardman 520
Ferrara 418
Milan 365
San Diego 344
Nanchang 323
Shenyang 303
Shanghai 297
Los Angeles 244
Warsaw 236
Hebei 204
Dearborn 203
Bremen 182
San Mateo 176
Changsha 173
Tianjin 173
Addison 170
Jiaxing 167
New York 164
Santa Clara 156
Jinan 119
Falls Church 115
Brussels 104
Hong Kong 102
Zhengzhou 102
Kunming 95
Auburn Hills 94
Norwalk 92
Mountain View 85
Jakarta 81
Ningbo 78
London 76
Rome 72
Philadelphia 70
Helsinki 66
Orange 63
Redwood City 63
Guangzhou 61
Düsseldorf 60
Munich 60
Florence 59
Verona 52
Des Moines 51
Dong Ket 46
Washington 44
Augusta 40
Lanzhou 39
Taizhou 39
Brno 37
Indiana 37
Tappahannock 36
Amsterdam 34
Bologna 33
Toronto 31
Chicago 30
Frankfurt am Main 29
Hangzhou 28
Redmond 27
Haikou 24
Torino 23
Olomouc 22
Ardabil 21
Bari 21
Naples 21
Hefei 20
Kilburn 20
Napoli 20
Ottawa 17
Leawood 16
Padova 16
Camerino 14
Catania 14
San Francisco 14
Cagliari 13
Espoo 13
Changchun 12
Ferrara di Monte Baldo 12
Turin 12
Aversa 11
Monmouth Junction 11
Taiyuan 11
Corvallis 9
Fuzhou 9
Meppel 9
Mumbai 9
Otura 9
Totale 38.142
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.165
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 333
Progetto ex 60%- I recettori dell’adenosina come possibili “biomarkers” dei tumori colorettali. Studio su tessuti umani sani e tumorali e sulle cellule del sangue periferico. 253
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 231
A glance at adenosine receptors: Novel target for antitumor therapy 196
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 194
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 192
The A3 adenosine receptor: history and perspectives 164
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 163
Pharmacology of Adenosine Receptors: The State of the Art 158
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 156
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 155
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 153
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 151
Recettori e trasduzione del segnale 151
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 150
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 148
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 146
2 Aralkynyl and 2-heteroalkynyl derivatives of adenosine 5'-N-ethyluronamide as selective A2A adenosine receptor agonists 145
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 145
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 145
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 144
Pathological overproduction: the bad side of adenosine 143
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 142
Adenosine receptors and human melanoma 142
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 142
Current status of A1 adenosine receptor allosteric enhancers 140
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 139
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 138
Adenosine receptor targeting in health and disease 136
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 136
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 136
7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (medazepam) 135
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 135
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells. 135
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 134
Octadecyl, phenyl and cyano phases comparison for the RP-HPLC prediction of octanol-water partition coefficient 133
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 133
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 133
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 132
Therapeutic potential of adenosine receptor antagonists and agonists 132
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 132
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 128
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 128
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 128
Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues 127
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 127
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 127
Comparison of Prazosin, Terazosin and Tamsulosin: Functional and Binding Studies in Isolated Prostatic and Vascular Human Tissues. 127
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 127
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 126
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 126
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 125
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 125
null 125
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 125
A Consensus Panel Review of Central Nervous System Effects of the Exposure to Low-Intensity Extremely Low-Frequency Magnetic Fields 125
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 125
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 124
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 124
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 124
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 124
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 124
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 123
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 123
Adenosine receptors and cancer 123
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 123
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 123
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 122
Temperature dependence of [3H]PAF binding to washed human platelets 122
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 122
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 121
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 121
null 121
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 120
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 120
Adenosine signaling contributes to ethanol-induced fatty liver in mice 119
Ala scan analogues of HOE 140. Synthesis and biological activities 119
Binding thermodynamics at A1 and A2A adenosine receptors 118
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 118
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 118
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 118
null 118
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 118
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 117
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 117
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 117
Cholesterol esters of the liver, of the plasma and of the lipoproteins of rats poisoned with CCl4 116
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 116
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 116
Recettori e trasduzione del segnale 116
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 116
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 116
Biochemical characterization of A1 adenosine receptors: experimental evaluation of their binding and intrinsic activity parameters 116
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 116
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 116
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 116
Rm and logP values of 5-nitroimidazoles 115
Antagonism towards endogenous adenosine and inhibition of cGIPDE in the cardiac effects amrinone, milrinone and related analogues 115
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 115
Totale 14.593
Categoria #
all - tutte 232.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.044
Totale 242.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.637 0 0 0 1.420 559 1.192 807 1.035 661 1.296 499 168
2020/20217.905 757 776 288 923 354 860 233 937 154 1.054 1.109 460
2021/20226.405 141 667 443 343 406 252 229 321 245 500 823 2.035
2022/20236.799 720 418 200 898 1.133 1.042 273 566 876 53 372 248
2023/20243.370 354 442 175 97 353 386 183 242 66 101 107 864
2024/20252.111 395 383 1.062 271 0 0 0 0 0 0 0 0
Totale 55.816